Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NMRANMRA
Showing 8 of 12 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NEUMORA THERAPEUTICS INC.

Yes. Citadel Advisors holds 828,933 shares of NMRA (Neumora Therapeutics), worth $1.4M, as of its Q2 2026 13F filing. It increased the position by 485,347 shares (+141.3%) from Q1 2026. Citadel Advisors has held NMRA since Q4 2025, across 3 quarterly 13F filings.

Current Value

$1.4M

Current Shares

828,933

Total Value Change

+$1.4M

Total Shares Change

+828,863

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
828,933
+141.3%
$1.4M0.0%$1.70
41
2026-Q1
Decreased
343,586
-32.1%
$669,9930.0%$3.06
0
2025-Q4
New
505,803
-
$905,3870.0%$1.77
34
2025-Q3
Exited
0
-100.0%
$00.0%$1.76
0
2025-Q2
New
17,187
-
$12,6030.0%$0.76
27
2025-Q1
Exited
0
-100.0%
$00.0%$1.03
0
2024-Q4
Increased
144,769
+2067x
$1.5M0.0%$11.06
41
2024-Q3
Decreased
70
-100.0%
$9250.0%$12.92
0

Other major holders of NMRA: SOFTBANK GROUP CORP., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used